Enanta Pharmaceuticals: Undervalued Potential Beyond Hepatitis C – Buy Recommendation by Roy Buchanan

TipRanksDec 13 23:05

Evercore Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Cuts Target Price to $20

Futu NewsDec 11 21:31 · Ratings

Oppenheimer Maintains Enanta Pharmaceuticals(ENTA.US) With Hold Rating, Maintains Target Price $14

Futu NewsDec 10 21:31 · Ratings

Enanta Pharmaceuticals (ENTA) Gets a Hold From Oppenheimer

TipRanksDec 10 21:07 · Ratings

JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $21

Futu NewsDec 10 03:31 · Ratings

Enanta Pharmaceuticals' RSV Platform Advances: Buy Rating Affirmed on Promising Clinical Data

TipRanksDec 10 02:45 · Ratings